Four biologics companies in Nevada underwent FDA inspections during the first quarter of 2026, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the second highest count of FDA visits by company type in Nevada, accounting for 33.3% of all inspections conducted in the state during the same period.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 1 | — | — |
| Blood and Blood Products | 4 | — | — |
| Compliance: Devices | — | 1 | — |
| Food Composition, Standards, Labeling and Econ | 1 | — | — |
| Foodborne Biological Hazards | 4 | 1 | — |
